(Q35612112)

English

Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway

scientific article published on June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

cholecalciferol

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Hong-Xia Li

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jing-Miao Gao

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jia-Qi Liang

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jun-Min Xi

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Meng Fu

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Yong-Jie Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

711-717

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Skeletal-related events and mortality among older men with advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Association of metformin use with cancer incidence and mortality: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

The BCL-2 protein family: opposing activities that mediate cell death

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

MYC on the path to cancer

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Metformin targets c-MYC oncogene to prevent prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12409

21 January 2018

Identifiers

10.1111/1440-1681.12409

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35612112&oldid=1856114962"